SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after a significant drop following mixed Phase 3 trial results, specifically related to high placebo response impacting statistical significance. The conversation centers on whether the sell-off is an overreaction given the company's cash reserves and ongoing pipeline, with some speculating about a potential buyout and others wary of the mixed data. Community members are actively discussing dip-buying strategies, potential bounce-back scenarios, and comparisons to competitor performance.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Shares of Robinhood are trending as the stock rallies to new all-time highs, fueled by optimism around its S&P 500 inclusion and growth in its prediction markets business; the community is closely watching for continued momentum. Several analysts have recently raised their price targets, with some traders speculating on further upside. The stock has become a favorite among millennial traders as it rides the crypto wave and wealth transfer megatrend.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a sharp drop in stock price following remarks made by a former FDA official, George Tidmarsh, regarding the drug Voclosporin. The community is expressing concerns about the validity and timing of the statement, with some suspecting market manipulation and questioning the company's leadership response. The drop has also impacted buyout hopes.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as cannabis stocks react to a video posted by Trump discussing the medical benefits of CBD for seniors, sparking community discussion around potential rescheduling.  Traders are actively weighing the implications of potential policy changes and the sector's volatile nature, while some highlight positive movement in European cannabis markets. The community speculates on the timing and impact of any official announcements.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending as investors anticipate the release of its preliminary feasibility study (PFS), with community members expressing excitement and speculating about potential partnerships and government support. Bullish sentiment is fueled by the company's strategic positioning in lithium extraction and battery recycling, as well as recent revenue gains. Some investors are drawing parallels to other successful stocks in the sector, while cautioning about potential short squeezes and profit-taking.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending following news of a partnership with Google to enhance AI-powered shopping experiences. While some investors are excited about the potential growth, others express frustration with the stock's historical underperformance and question whether the partnership will provide an immediate catalyst. Community members are debating whether this is a turning point or another false start for the fintech giant.

Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.

Boqii Holding Limited - Ordinary Shares - Class A

Boqii Holding Limited - ADR

Boqii Holding is trending due to speculation around a potential gamma squeeze and significant price movement, leading to community discussions about float size and potential price targets. Some traders are pointing to technical indicators and chart patterns, while others caution about the risks associated with Chinese stocks and potential pump-and-dump schemes. The stock's volatility and history of reverse splits are also prominent points of discussion among investors.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending following a strong earnings report, with revenue and GMV growth exceeding expectations. The community is discussing the company's resilience in the face of potential headwinds like tariffs, along with its expanding partnerships and AI initiatives. Bullish sentiment is fueled by raised price targets and the anticipation of continued growth, though some caution against overvaluation.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending, sparking community engagement around the classic 'What's UpDog?' joke. Built on Solana and listed on Jupiter, the community emphasizes its longevity and strong holder base. The conversation also highlights the accessibility of becoming an $UPDOG millionaire.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals (ENTA) is trending due to mixed Phase 2b study results for its RSV treatment, zelicapavir, causing investor debate and a stock sell-off. While the primary endpoint was missed, secondary endpoints were met, fueling discussions about the drug's potential and Phase 3 progression, particularly regarding FDA priorities. Community talking points include potential short squeezes given the high short interest and oversold RSI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of ASP Isotopes (ASPI) closed 6.1% higher at $9.36 on Friday.Last week, the company struck a four-year supply agreement with Isotopia Molecular Imaging to deliver enriched Gadolinium-160 (Gd-160), a key ingredient in producing Terbium-161 (Tb-161), a promising isotope for targeted radiotherapeutics.ASP will supply the isotope using its proprietary Quantum Enrichment technology from 2026, and&nbsp;the deal is expected to generate at least $1 million per year.The agreement is designed to help overcome persistent supply shortages of Gd-160, enabling Isotopia to advance its Tb-161-based treatments for cancers like prostate and neuroendocrine tumors.“By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry’s growing demand for stable isotopes,” said Paul Mann, CEO of ASP Isotopes.“This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms.”Last month, ASP signed a deal to supply enriched uranium to TerraPower, the nuclear energy company backed by Bill Gates.&nbsp;As part of the agreement, TerraPower will provide ASP with a multiple-advance term loan to help fund a planned uranium enrichment facility at Pelindaba, South Africa.Retail sentiment on Stocktwits remained ‘bullish’ ahead of Monday’s trading session.<figure class="image"><img style="aspect-ratio:969/96;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_122253_png_3a77496e48.webp" alt="Screenshot 2025-06-09 122253.png" width="969" height="96"><figcaption>ASPI's Sentiment Meter and Message Volume as of 3:17 a.m ET on June 9, 2025 | Source: Stocktwits&nbsp;</figcaption></figure>One user believes the stock should reach at least $20 before considering selling.<stembedurl>https://stocktwits.com/trent1229/message/617231598</stembedurl><a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained over 100% year-to-date.

DocuSign expects the new agreement to expedite the advancement of its IAM platform and deliver more intelligent and efficient solutions to its customers. 

ASP Isotopes Stock Jumps On Isotopia And TerraPower Tie-Ups: Retail Stays Bullish

The Isotopia agreement aims to deliver enriched Gadolinium-160 (Gd-160) to aid targeted radiotherapeutics

Equity

ASP Isotopes (ASPI) stock jumped in extended trading on Monday after the company signed an agreement to supply enriched uranium to Bill Gates-backed nuclear energy firm TerraPower.Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment facility at Pelindaba, South Africa.The facility would be capable of producing high-assay low-enriched uranium (HALEU) with an annual output of approximately 15 metric tons.The company also agreed to supply HALEU for the first fuel core for TerraPower’s Natrium Plant in Wyoming. ASP expects to provide 150 metric tons of HALEU from 2028 through the end of 2037.The South Africa facility is expected to begin operations in 2027 upon receipt of all required permits and licenses.Monday’s agreement finalized a term sheet agreement between the two companies, which was struck last year.“Nuclear fuel has one of the most severely compromised supply chains of any material in the world. The world is in urgent need of additional suppliers,” ASP CEO Paul Mann said.HALEU is enriched between 5% and 20% and is the key to many advanced, smaller reactors with more power per unit of volume.There is a broad bipartisan support for nuclear power, which the U.S. lawmakers believe could be the answer to the rapid rise in power demand. However, currently, Russia is the only viable HALEU supplier of scale.The companies said they would explore opportunities to produce HALEU within the U.S.Retail sentiment on Stocktwits was in the ‘extremely bullish’ (81/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:878/102;" src="https://news.stocktwits-cdn.com/ASPI_May_20_JPG_2e0ea8a23b.webp" alt="ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits" width="878" height="102"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits</figcaption></figure>“This feels like where we were before Fuzzy Panda. This time, though, even though its prospects and potential are the same as then, the company is in a stronger position,” one retail trader said.<stembedurl>https://stocktwits.com/wilmeriken/message/615185094</stembedurl>The stock declined in November after short seller Fuzzy Panda <a href="https://stocktwits.com/news-articles/markets/equity/aspi-stock-slides-after-fuzzy-panda-short-call/cJIWDFNRWc">accused the company</a> of misleading investors. ASP had denied the allegations.<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained 60% year to date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/citi-downgrades-patterson-uti-helmerich-and-payne-on-oil-price-risk/ch0dF7jRb8M">Citi Downgrades Patterson-UTI, Helmerich &amp; Payne On Oil Price Risk — Retail Surprised By ‘Brutal’ Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower — Retail Says Company Can Finally Move Beyond Short-Seller Report

Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment in South Africa.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ASP Isotopes Inc. (NASDAQ: ASPI)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ASP Isotopes Inc. (NASDAQ: ASPI) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

4 Top-Rated Nuclear Energy Stocks to Buy in February 2025

These nuclear energy stocks all are loved by analysts and have significant upside potential over the next 12 months.

ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the Schall Law Firm

ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the Schall Law Firm ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the...

Final Deadline for the ASP Isotopes Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ASP

Final Deadline for the ASP Isotopes Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ASP Final Deadline for the ASP Isotopes Inc. Securities Lawsuit - Contact the DJS Law...

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ASP Isotopes

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ASP Isotopes Inc. (ASP Isotopes or the Company) (NASDAQ: ASPI) and reminds investors of the...

Investors in ASP Isotopes Inc. Should Contact The Gross Law Firm Before February 3, 2025 to Discuss Your Rights - ASPI

Investors in ASP Isotopes Inc. Should Contact The Gross Law Firm Before February 3, 2025 to Discuss Your Rights - ASPI Investors in ASP Isotopes Inc. Should Contact The Gross Law Firm Before February...

ASPI Deadline: Rosen Law Firm Urges ASP Isotopes Inc. (NASDAQ: ASPI) Stockholders with Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of ASP Isotopes Inc. (NASDAQ: ASPI) securities...

ASPI Deadline: ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit

ASPI Deadline: ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit ASPI Deadline: ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit PR...

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$10.57
Prev Close	$10.55
Open	$10.66
Dividend Yield	0.00%
50-Day Moving Average	$9.59
Beta	2.33
Avg. Volume	4.51M
PE Ratio	-7.55

52-Week High	$11.86
52-Week Low	$2.61
Market Capitalization	$969.68M
EPS (Annual)	-$0.6307
Price to Book	35.08
Revenue Per Employee	$30,472.25
Enterprise Value/EBITDA	N/A

ASPI
ASP Isotopes Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASPI News

ASPI ASP Isotopes Inc